2017
DOI: 10.5009/gnl16365
|View full text |Cite
|
Sign up to set email alerts
|

Extrahepatic Manifestations of Primary Biliary Cholangitis

Abstract: Primary biliary cholangitis (PBC) is an autoimmune liver disease characterized by progressive destruction of the intrahepatic bile ducts, leading to cholestasis. PBC is known to have both hepatic and extrahepatic manifestations. Extrahepatic manifestations are seen in up to 73% of patients with PBC, with the most common being Sjogren’s syndrome, thyroid dysfunction and systemic sclerosis. It is thought that patients with PBC are at increased risk of developing these extrahepatic manifestations, almost all of w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
51
0
3

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 83 publications
(58 citation statements)
references
References 104 publications
4
51
0
3
Order By: Relevance
“…PBC is often associated with extrahepatic autoimmune disorders, such as Sjögren syndrome, thyroid disorders, systemic sclerosis, and rheumatoid arthritis. 4 …”
Section: Introductionmentioning
confidence: 99%
“…PBC is often associated with extrahepatic autoimmune disorders, such as Sjögren syndrome, thyroid disorders, systemic sclerosis, and rheumatoid arthritis. 4 …”
Section: Introductionmentioning
confidence: 99%
“…Bone mineral density loss is also common, and all patients with PBC should be offered calcium/vitamin D supplementation, and bisphosphonate therapy if osteoporotic. 4…”
Section: Primary Biliary Cholangitismentioning
confidence: 99%
“…Autoimmune thyroid diseases (AITD), featured by the production of autoantibody which induced by abnormal autoimmune responses and targets thyroid cells, is a class of organ-specific autoimmune disease, and mainly including Hashimoto's thyroiditis (HT) and Graves' disease (GD). AILD frequently overlap other extrahepatic autoimmune disease (EHAID) [1][2][3], AITD is the commonest concurrent EHAID in AILD patients (10-23%) [4][5][6]. The high incidence of AILD concomitant with AITD may be closely relevant to its underlying pathogenesis.…”
Section: Introductionmentioning
confidence: 99%